Skip to content
Riskpilot
← Back to search
Sign in
Get full access
BIOSORT AS
AS
Active
Org 996343545
Martin Linges Vei 25, 1364
Fornebu
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2010 · 15 years old
25 employees
www.biosort.no
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
BIOSORT AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
TH
Tore Hopen
Observer
Observer
2025
GS
Geir Stang Hauge
Chief Executive Officer
Chief Executive Officer
2016
Board of directors
Non-executive oversight
Name
Role
Member since
Current (6)
CA
Carsten Alexander Krome
Board of Directors
Board of Directors
2025
MB
Morten Bøklepp Mjøen
Board of Directors
Board of Directors
2025
GM
Geir Molvik
Board of Directors
Board of Directors
2023
PB
Pål Brynsrud
Board of Directors
Board of Directors
2023
SG
Stian Grieg
Board of Directors
Board of Directors
2025
ST
Svein Tore Idsø
Chairman
Chairman
2023
Former (3)
BS
Bernt Saugen
Board of Directors
Board of Directors
2023 – 2025
WA
Wilhelm Anton Mohn
Board of Directors
Board of Directors
2023 – 2024
PD
Petter Dragesund
Board of Directors
Board of Directors
2023 – 2025
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Idsø Invest As
Company
17.62%
17.62%
2025
Timax As
Company
17.62%
17.62%
2025
Avatara As
Company
17.62%
17.62%
2025
Blue Revolution Fund L.P.
Company
8.16%
8.16%
2025
Grieg Kapital As
Company
8.16%
8.16%
2025
Ivc As
Company
8.16%
8.16%
2025
Farvatn Private Equity As
Company
8.16%
8.16%
2025
Futurum Ventures Fund I As
Company
4.08%
4.08%
2025
Dragesund Invest As
Company
3.41%
3.41%
2025
Mango Holding As
Company
3.21%
3.21%
2025
Cvp Invest As
Company
2.97%
2.97%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on BIOSORT AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network